Back to article: Amelioration of obesity-induced diabetes by a novel autophagy enhancer


FIGURE 2: Reversal of MSL-7-induced metabolic improvement in HDF-fed mice by an autophagy inhibitor. MSL-7 was administered to mice fed HFD for 8 weeks with or without DMKG, an inhibitor of autophagy. Nonfasting blood glucose level was monitored during administration of MSL-7 and DMKG to HFD-fed mice for 8 weeks (left). Intraperitoneal glucose tolerance test was conducted after 8 weeks of administration (right).

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close